[HTML][HTML] Glucose transporters in brain in health and disease
H Koepsell - Pflügers Archiv-European Journal of Physiology, 2020 - Springer
Energy demand of neurons in brain that is covered by glucose supply from the blood is
ensured by glucose transporters in capillaries and brain cells. In brain, the facilitative …
ensured by glucose transporters in capillaries and brain cells. In brain, the facilitative …
Diabetes and cognitive impairment
LA Zilliox, K Chadrasekaran, JY Kwan… - Current diabetes …, 2016 - Springer
Abstract Both type 1 (T1DM) and type 2 diabetes mellitus (T2DM) have been associated with
reduced performance on multiple domains of cognitive function and with evidence of …
reduced performance on multiple domains of cognitive function and with evidence of …
Hippocampal insulin resistance and cognitive dysfunction
GJ Biessels, LP Reagan - Nature Reviews Neuroscience, 2015 - nature.com
Clinical studies suggest a link between type 2 diabetes mellitus (T2DM) and insulin
resistance (IR) and cognitive dysfunction, but there are significant gaps in our knowledge of …
resistance (IR) and cognitive dysfunction, but there are significant gaps in our knowledge of …
Insulin signaling pathway and related molecules: role in neurodegeneration and Alzheimer's disease
Alzheimer's disease (AD) is one of the most common neurodegenerative diseases. Its major
pathological hallmarks, neurofibrillary tangles (NFT), and amyloid-β plaques can result from …
pathological hallmarks, neurofibrillary tangles (NFT), and amyloid-β plaques can result from …
Is there a “metabolic-mood syndrome”? A review of the relationship between obesity and mood disorders
RB Mansur, E Brietzke, RS McIntyre - Neuroscience & Biobehavioral …, 2015 - Elsevier
Obesity and mood disorders are highly prevalent and co-morbid. Epidemiological studies
have highlighted the public health relevance of this association, insofar as both conditions …
have highlighted the public health relevance of this association, insofar as both conditions …
Link between type 2 diabetes and Alzheimer's disease: from epidemiology to mechanism and treatment
X Li, D Song, SX Leng - Clinical interventions in aging, 2015 - Taylor & Francis
The aim of this paper is to provide a comprehensive review of the epidemiological evidence
linking type 2 diabetes mellitus and its related conditions, including obesity …
linking type 2 diabetes mellitus and its related conditions, including obesity …
[HTML][HTML] Decreased microglial activation through gut-brain axis by prebiotics, probiotics, or synbiotics effectively restored cognitive function in obese-insulin resistant …
T Chunchai, W Thunapong, S Yasom… - Journal of …, 2018 - Springer
Background Chronic high-fat diet (HFD) consumption caused not only obese-insulin
resistance, but also cognitive decline and microglial hyperactivity. Modified gut microbiota by …
resistance, but also cognitive decline and microglial hyperactivity. Modified gut microbiota by …
Effects of high-fat diet exposure on learning & memory
ZA Cordner, KLK Tamashiro - Physiology & behavior, 2015 - Elsevier
The associations between consumption of a high-fat or 'Western'diet and metabolic
disorders such as obesity, diabetes, and cardiovascular disease have long been recognized …
disorders such as obesity, diabetes, and cardiovascular disease have long been recognized …
Obesity as a risk factor for Alzheimer's disease: weighing the evidence
S Alford, D Patel, N Perakakis, CS Mantzoros - Obesity reviews, 2018 - Wiley Online Library
Alzheimer's disease (AD) is the sixth leading cause of death in the USA today; therefore, it is
imperative that public health initiatives and clinical strategies are developed to prevent and …
imperative that public health initiatives and clinical strategies are developed to prevent and …
SGLT2-inhibitor and DPP-4 inhibitor improve brain function via attenuating mitochondrial dysfunction, insulin resistance, inflammation, and apoptosis in HFD-induced …
P Sa-Nguanmoo, P Tanajak, S Kerdphoo… - Toxicology and applied …, 2017 - Elsevier
Abstract Dipeptidyl peptidase-4 inhibitor (vildagliptin) has been shown to exert beneficial
effects on insulin sensitivity and neuroprotection in obese-insulin resistance. Recent studies …
effects on insulin sensitivity and neuroprotection in obese-insulin resistance. Recent studies …